Market Closed -
Hong Kong S.E.
04:08:05 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
3.28
HKD
|
-8.64%
|
|
+11.56%
|
-22.64%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
90,747
|
142,817
|
249,927
|
55,562
|
67,140
|
48,848
|
-
|
-
|
Enterprise Value (EV)
1 |
90,430
|
140,292
|
238,291
|
55,562
|
56,300
|
47,219
|
37,747
|
35,237
|
P/E ratio
|
-1,048
x
|
-19,731
x
|
708
x
|
-209
x
|
126
x
|
46.8
x
|
28.7
x
|
24
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.8
x
|
14.9
x
|
16.1
x
|
2.7
x
|
2.51
x
|
1.75
x
|
1.56
x
|
1.29
x
|
EV / Revenue
|
17.7
x
|
14.6
x
|
15.4
x
|
2.7
x
|
2.1
x
|
1.75
x
|
1.21
x
|
0.93
x
|
EV / EBITDA
|
-3,321
x
|
-2,546
x
|
529
x
|
-53.7
x
|
1,763
x
|
67.8
x
|
24.2
x
|
18.4
x
|
EV / FCF
|
232
x
|
246
x
|
246
x
|
136
x
|
225
x
|
38.3
x
|
20.3
x
|
14.5
x
|
FCF Yield
|
0.43%
|
0.41%
|
0.41%
|
0.74%
|
0.44%
|
2.61%
|
4.92%
|
6.91%
|
Price to Book
|
30.7
x
|
26.8
x
|
17.2
x
|
3.93
x
|
4.43
x
|
2.72
x
|
2.87
x
|
2.46
x
|
Nbr of stocks (in thousands)
|
11,700,591
|
12,063,834
|
13,477,663
|
13,507,505
|
13,511,061
|
16,081,435
|
-
|
-
|
Reference price
2 |
7.756
|
11.84
|
18.54
|
4.113
|
4.969
|
3.038
|
3.038
|
3.038
|
Announcement Date
|
5/16/19
|
5/27/20
|
5/25/21
|
5/25/22
|
5/23/23
|
5/27/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,096
|
9,596
|
15,518
|
20,578
|
26,763
|
27,027
|
31,260
|
37,782
|
EBITDA
1 |
-27.23
|
-55.1
|
450.2
|
-1,034
|
31.93
|
559.8
|
1,561
|
1,912
|
EBIT
1 |
-31.22
|
-62.41
|
442.1
|
-1,094
|
-31.79
|
640.2
|
1,496
|
1,805
|
Operating Margin
|
-0.61%
|
-0.65%
|
2.85%
|
-5.32%
|
-0.12%
|
2.37%
|
4.79%
|
4.78%
|
Earnings before Tax (EBT)
1 |
-60.83
|
9.094
|
401.2
|
-252.5
|
551
|
939.4
|
1,792
|
2,118
|
Net income
1 |
-81.95
|
-6.586
|
348.6
|
-265.6
|
533.4
|
883.5
|
1,609
|
1,793
|
Net margin
|
-1.61%
|
-0.07%
|
2.25%
|
-1.29%
|
1.99%
|
3.27%
|
5.15%
|
4.75%
|
EPS
2 |
-0.007400
|
-0.000600
|
0.0262
|
-0.0197
|
0.0394
|
0.0627
|
0.1057
|
0.1265
|
Free Cash Flow
1 |
390.3
|
570.1
|
967.4
|
409.4
|
250.1
|
991.6
|
1,856
|
2,435
|
FCF margin
|
7.66%
|
5.94%
|
6.23%
|
1.99%
|
0.93%
|
3.48%
|
5.94%
|
6.45%
|
FCF Conversion (EBITDA)
|
-
|
-
|
214.88%
|
-
|
783.16%
|
177.14%
|
118.95%
|
127.38%
|
FCF Conversion (Net income)
|
-
|
-
|
277.52%
|
-
|
46.88%
|
129.39%
|
115.36%
|
135.82%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/16/19
|
5/27/20
|
5/25/21
|
5/25/22
|
5/23/23
|
5/27/24
|
-
|
-
|
Fiscal Period: March |
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
9,358
|
11,220
|
11,501
|
15,262
|
12,956
|
14,071
|
14,292
|
16,663
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
555
|
865
|
EBIT
1 |
-204.7
|
-
|
-30.05
|
-1.738
|
261.6
|
378.5
|
434
|
738
|
Operating Margin
|
-2.19%
|
-
|
-0.26%
|
-0.01%
|
2.02%
|
2.69%
|
3.04%
|
4.43%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
174
|
-
|
481.3
|
458.1
|
677
|
993
|
Net income
1 |
-
|
-
|
160.7
|
372.7
|
445.9
|
437.6
|
643
|
943
|
Net margin
|
-
|
-
|
1.4%
|
2.44%
|
3.44%
|
3.11%
|
4.5%
|
5.66%
|
EPS
2 |
-
|
-
|
0.0100
|
0.0275
|
0.0329
|
0.0298
|
0.0500
|
0.0700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/24/21
|
5/25/22
|
11/28/22
|
5/23/23
|
11/28/23
|
5/27/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
317
|
2,525
|
11,637
|
-
|
10,839
|
10,911
|
11,101
|
13,611
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
390
|
570
|
967
|
409
|
250
|
992
|
1,856
|
2,435
|
ROE (net income / shareholders' equity)
|
-3.05%
|
6.48%
|
6.44%
|
-1.87%
|
3.64%
|
5.44%
|
10.8%
|
10.6%
|
ROA (Net income/ Total Assets)
|
-1.8%
|
-0.16%
|
4.93%
|
-1.44%
|
2.67%
|
3.66%
|
7.59%
|
7.65%
|
Assets
1 |
4,546
|
4,032
|
7,078
|
18,471
|
19,975
|
20,962
|
21,209
|
23,436
|
Book Value Per Share
2 |
0.2500
|
0.4400
|
1.080
|
1.050
|
1.120
|
1.120
|
1.060
|
1.230
|
Cash Flow per Share
2 |
0.0400
|
0.0500
|
0.0800
|
-
|
0.0200
|
0.0700
|
0.1100
|
0.1500
|
Capex
1 |
6.1
|
13.5
|
17.1
|
14.9
|
5.61
|
17.8
|
17
|
17
|
Capex / Sales
|
0.12%
|
0.14%
|
0.11%
|
0.07%
|
0.02%
|
0.06%
|
0.05%
|
0.05%
|
Announcement Date
|
5/16/19
|
5/27/20
|
5/25/21
|
5/25/22
|
5/23/23
|
5/27/24
|
-
|
-
|
Last Close Price
3.038
CNY Average target price
4.961
CNY Spread / Average Target +63.31% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.64% | 6.75B | | -37.88% | 13.99B | | -33.12% | 10.67B | | +12.54% | 6.29B | | -11.17% | 5.88B | | +75.00% | 4.96B | | -4.38% | 4.54B | | -9.20% | 3.74B | | -19.40% | 3.16B | | -12.15% | 2.85B |
Other Drug Retailers
|